Reposted by Promita Ghosh (she/her)
Authoritative review from The one and only @ghoshonthemove.bsky.social ☺️on her doctoral work on NSCLC 🫁 @mcgillgci.bsky.social
portlandpress.com/biochemsoctr...
Need to stay tuned to see if these mutations can generate targetable neoantigens in tricky low-TMB cancers
portlandpress.com
Mechanistic insights into MET exon 14 skipping mutations and their role in tumor progression
The MET receptor tyrosine kinase is a pivotal regulator of cellular survival, motility, and proliferation. Mutations leading to skipping of exon 14 (METΔex14) within the juxtamembrane domain of MET im...